Andrew Hopkins of Exscientia: the man using AI to cure disease
The Guardian - Pharmaceutical Industry
JULY 30, 2022
The British scientist’s company employs artificial intelligence to drastically cut the time of drug development It was early one morning in 1996 when Andrew Hopkins, then a PhD biophysics student at Oxford University, had a brainwave as he walked home from a late-night lab meeting. He was trying to find molecules to fight HIV and to better understand drug resistance.
52 
Let's personalize your content